Cite
MLA Citation
Y.H. Kim et al.. “TIME TO NEXT TREATMENT IN PATIENTS WITH PREVIOUSLY TREATED CUTANEOUS T‐CELL LYMPHOMA (CTCL) RECEIVING MOGAMULIZUMAB OR VORINOSTAT: A POST‐HOC ANALYSIS OF THE MAVORIC STUDY.” Hematological oncology, vol. 37, n.d., pp. 285–286. http://access.bl.uk/ark:/81055/vdc_100086192555.0x000036